Bank of New York Mellon Corp - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 72 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$119,000
-7.8%
195,528
-1.4%
0.00%
Q1 2017$129,000
+115.0%
198,296
+1.9%
0.00%
Q4 2016$60,000
-33.3%
194,564
-7.1%
0.00%
Q3 2016$90,000
+3.4%
209,444
-12.7%
0.00%
Q2 2016$87,000
-72.2%
239,952
-67.7%
0.00%
Q1 2016$313,000
-62.1%
744,009
+5.3%
0.00%
Q4 2015$826,000
+14.9%
706,249
+0.1%
0.00%
Q3 2015$719,000
-36.9%
705,446
-18.9%
0.00%
Q2 2015$1,139,000
+5.1%
869,488
+8.3%
0.00%
Q1 2015$1,084,000
-10.2%
802,537
-7.5%
0.00%
Q4 2014$1,207,000
+1.8%
868,005
-0.5%
0.00%
Q3 2014$1,186,000
-66.2%
872,033
-53.2%
0.00%
Q2 2014$3,506,000
+109.1%
1,864,978
+111.3%
0.00%
Q1 2014$1,677,000
+61.1%
882,805
+17.9%
0.00%
Q4 2013$1,041,000
-50.9%
749,076
-50.5%
0.00%
Q3 2013$2,120,000
+140.1%
1,514,158
+121.1%
0.00%
Q2 2013$883,000684,8530.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q4 2013
NameSharesValueWeighting ↓
BAXTER BROS INC 148,006$206,0000.10%
First Heartland Consultants, Inc. 86,204$120,0000.07%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 671,900$934,0000.02%
Investors Capital Advisory Services 47,238$65,0000.02%
PINNACLE FINANCIAL PARTNERS INC 20,000$28,0000.01%
Commonwealth Equity Services, Inc 481,140$669,0000.01%
REYNOLDS CAPITAL MANAGEMENT LLC 11,300$16,0000.01%
First Allied Advisory Services, Inc. 50,000$70,0000.01%
Winslow, Evans & Crocker, Inc. 13,200$18,0000.01%
AMALGAMATED BANK 16,650$23,0000.00%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders